Latest Articles

Publication Date
All News Scientific
Metformin in gynecological disorders: pathogenic insights and therapeutic implications - Frontiers

Metformin in gynecological disorders: pathogenic insights and therapeutic implications Frontiers

Published: March 31, 2025, 10:26 a.m.
Read Full Article
University of Cincinnati Cancer Center Reports Metformin Enhances Treatment in ER-Positive Endometrial Cancer - Hoodline

University of Cincinnati Cancer Center Reports Metformin Enhances Treatment in ER-Positive Endometrial Cancer Hoodline

Published: March 24, 2025, 7:46 p.m.
Read Full Article
Add-on metformin promising in ER-positive endometrial cancer - University of Cincinnati

Add-on metformin promising in ER-positive endometrial cancer University of Cincinnati

Published: March 24, 2025, 5:05 p.m.
Read Full Article
Metformin Restores Endometrial Health in PCOS - Technology Networks

Metformin Restores Endometrial Health in PCOS Technology Networks

Published: March 21, 2025, 9:03 p.m.
Read Full Article
Metformin With IUD Boosts Responses in EIN and Endometrial Cancer - OncLive

Metformin With IUD Boosts Responses in EIN and Endometrial Cancer OncLive

Published: March 17, 2025, 1:37 p.m.
Read Full Article
Add-On Metformin Promising in ER-Positive Endometrial Cancer - MSN

Add-On Metformin Promising in ER-Positive Endometrial Cancer MSN

Published: March 17, 2025, 8:41 a.m.
Read Full Article
Add-On Metformin Promising in ER-Positive Endometrial Cancer - Medpage Today

Add-On Metformin Promising in ER-Positive Endometrial Cancer Medpage Today

Published: March 16, 2025, 7:53 p.m.
Read Full Article
Metformin Plus IUD Well-Tolerated in EIN/Endometrial Cancer - Cancer Network

Metformin Plus IUD Well-Tolerated in EIN/Endometrial Cancer Cancer Network

Published: March 16, 2025, 7:52 p.m.
Read Full Article
Prescription patterns and the cost of antihyperglycemic drugs in patients with diabetes mellitus in Iran from 2014 to 2019.

Diabetes mellitus (DM) is characterized by high blood glucose levels and abnormalities in metabolism. In 2021, 15.14% of adult Iranians had DM. The purpose of this study is to provide …

Published: March 15, 2025, midnight
Read Full Article
Antidiabetic drugs Cost Diabetes mellitus Insulin Iran Metformin Prescription patterns Sulfonylureas
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial - Nature.com

Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial Nature.com

Published: Feb. 20, 2025, 9:18 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!